51
Participants
Start Date
October 3, 2013
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
RSV cps2 Vaccine
10\^5.3 plaque forming units (PFUs) or RSV cps2 vaccine will be administered as nose drops (0.25 mL per nostril, for a total of 0.5 mL).
Placebo Vaccine
Placebo vaccine will be administered as nose drops (0.25 mL per nostril, for a total of 0.5 mL).
Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago
The Children's Hospital University of Colorado, Denver
Miller Children's Hospital at Long Beach Memorial Medical Center, Long Beach
University of California, UC San Diego CRS, La Jolla
Chicago Children's CRS, Chicago
National Institute of Allergy and Infectious Diseases (NIAID)
NIH